Results 1 to 10 of about 77,915 (259)

Systemic vasculitis and headache. [PDF]

Curr Opin Neurol, 2023
Purpose of review Vasculitis refers to heterogeneous clinicopathologic disorders that share the histopathology of inflammation of blood vessels. Unrecognized and therefore untreated, vasculitis of the nervous system or so called neurovasculitides, lead to pervasive injury and disability making these disorder of paramount ...
Younger DS.
europepmc   +3 more sources

Plasmapheresis for systemic vasculitis. [PDF]

Ther Apher Dial, 2022
AbstractSystemic vasculitides include a variety of, and numerous diseases. In 2012, the International CHAPEL HILL Consensus Conference (CHCC2012) led to a major reorganization of the classification of vasculitis, and this is still in wide use today. Although the results of plasmapheresis for individual diseases have been sometimes shown, there are few ...
Fukuoka K, Kishimoto M, Kawakami T, Komagata Y, Kaname S.   +4 more
europepmc   +3 more sources

Autoantibodies in systemic vasculitis [PDF]

Frontiers in Immunology, 2015
Systemic vasculitis is a heterogeneous group of disorders characterized by inflammation and necrosis in the vessel wall. The diagnosis of a systemic vasculitis is challenging, because patients usually present a broad spectrum of manifestations that vary according to the predominant size of vessels affected, organs and systems involved, and the extent ...
Alexandre Wagner Silva De Souza
doaj   +3 more sources

Pregnancy and Systemic Vasculitis [PDF]

Indian Journal of Rheumatology, 2016
The systemic vasculitides are rare diseases of vessel wall inflammation. They are classified according to the vessel wall size. Systemic vasculitis is usually diagnosed after the fifth decade of life, except Takayasu arteritis and Bechet's disease which can manifest earlier.
Himanshu Pathak, Chetan Mukhtyar
doaj   +3 more sources

Immunogenicity and safety to SARS-Cov-2 vaccination in patients with systemic vasculitis [PDF]

Frontiers in Immunology
Background/objectivesPatients with systemic vasculitis faced the risk of severe COVID-19 and high mortality during the pandemic. Although SARS-CoV-2 vaccination mitigates these outcomes, vaccine hesitancy persists, and data on immunogenicity and safety ...
Erika Biegelmeyer, Mariana de Freitas Aguiar, Priscila Dias Cardoso Ribeiro, Ketty Lysie Libardi Lira Machado, Camila Maria Paiva França Telles, Sandra Lúcia Euzébio Ribeiro, Natália Sarzi Sartori, Rodrigo Poubel Vieira de Rezende, Ana Karla Guedes de Melo, Vitor Alves Cruz, Rejane Maria Rodrigues de Abreu Vieira, Adriana Maria Kakehasi, Maria Cecília Dias Corrêa, Valderilio Feijó Azevedo, Olindo Assis Martins-Filho, Flávia Maria Matos Melo Campos Peixoto, Vanessa de Oliveira Magalhães, Maria da Penha Gomes Gouveia, Thaís Evelyn Karnopp, Katia Lino Baptista, Tâmara Santos Melo, Jozelia Rêgo, Adah Sophia Rodrigues Vieira, Anna Carolina Faria Moreira Gomes Tavares, Victória Dornelas Paz Carvalho, Vanessa Peruhype-Magalhães, Laiza Hombre Dias, Raquel Lima de Lima, Kimberly Rossana da Silva Gonçalves, Natália Rodrigues Querido Fortes, Débora Marques Veghini, Jônatas Almeida Amorim, Raiza Casian Tuão, Karina Rosemarie Lallemand Tapia, Cristiane Kayser, Charlles Heldan de Moura Castro, Maressa Barbosa Beloni Lirio, Juliana Bühring, Ricardo Machado Xavier, Andréa Teixeira-Carvalho, Viviane Angelina de Souza, Odirlei André Monticielo, Gilda Aparecida Ferreira, Marcelo de Medeiros Pinheiro, Edgard Torres dos Reis Neto, Emilia Inoue Sato, Valeria Valim, Gecilmara Salviato Pileggi, Alexandre Wagner Silva de Souza   +48 more
doaj   +2 more sources

Systemic vasculitis with latent tuberculosis infection and associated factors: a cross-sectional multicenter study [PDF]

Clinical Rheumatology
Xiaochun Shi, Baotong Zhou, Zhang Lifan   +2 more
exaly   +2 more sources

The modern therapy of systemic vasculitides: perspectives and challenges [PDF]

Терапевтический архив, 2018
Systemic vasculitis is a heterogeneous group of inflammatory diseases, which are classified according to the diameter of the affected vessels. The treatment of systemic vasculitis is no longer empirical, because of increasing number of randomized ...
P I Novikov, A S Zykova, S V Moiseev
doaj   +3 more sources

Voclosporin and the Antiviral Effect Against SARS-CoV-2 in Immunocompromised Kidney Patients

Kidney International Reports, 2023
Introduction: Immunocompromised kidney patients are at increased risk of prolonged SARS-CoV-2 infection and related complications. Preclinical evidence demonstrates a more potent inhibitory effect of voclosporin on SARS-CoV-2 replication than tacrolimus ...
Eline J. Arends, Soufian Meziyerh, Dirk Jan A.R. Moes, Sylvia W.A. Kamerling, Sandra van der Kooy, Natacha S. Ogando, Eric J. Snijder, Martijn van Hemert, Leo G. Visser, Mariet C.W. Feltkamp, Eric C.J. Claas, Ton J. Rabelink, Cees van Kooten, Aiko P.J. de Vries, Y.K. Onno Teng   +14 more
doaj   +1 more source

Efficacy of belimumab combined with rituximab in severe systemic lupus erythematosus: study protocol for the phase 3, multicenter, randomized, open-label Synbiose 2 trial

Trials, 2022
Background Belimumab, an anti-B-cell activating factor antibody, is approved for the treatment of auto-antibody positive systemic lupus erythematosus with a high degree of disease activity.
Mieke van Schaik, Eline J. Arends, Darius Soonawala, Ellen van Ommen, Karina de Leeuw, Maarten Limper, Pieter van Paassen, Tom W. J. Huizinga, René E. M. Toes, Cees van Kooten, Joris I. Rotmans, Ton J. Rabelink, Y. K. Onno Teng   +12 more
doaj   +1 more source

Highly Sensitive Flow Cytometric Detection of Residual B-Cells After Rituximab in Anti-Neutrophil Cytoplasmic Antibodies-Associated Vasculitis Patients

Frontiers in Immunology, 2020
BackgroundB-cell depletion with rituximab (RTX) is an effective treatment for anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV) patients.
Laura S. van Dam, Jelle M. Oskam, Sylvia W. A. Kamerling, Eline J. Arends, O. W. Bredewold, Magdalena A. Berkowska, Jacques J. M. van Dongen, Ton J. Rabelink, Cees van Kooten, Y. K. Onno Teng   +9 more
doaj   +1 more source